- Price
- $68.07
- Day
- -0.28%
- Mkt Cap
- $113.66B
- 52W Range
- $54.70 – $77.06
- Volume
- 8.22M
- Beta
- 0.49
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
MO's pricing power supports smokeable revenues and profit despite declining cigarette volumes and a growing shift toward discount brands.
Read full article
Altria remains an attractive dividend payer, but its overreliance on declining smokable products tempers my previous bullish outlook. MO's Q2 and H1 results revealed flat real revenue growth and continued struggles to diversify meaningfully into e-vapor and oral tobacco. Despite failed diversification attempts, MO's strong cash generation and pricing power support a fair value estimate of $76 per share—12% upside.
Read full article
/PRNewswire/ -- Full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72 was reaffirmed by Altria Group (NYSE: MO) Chief Financial Officer Sal Mancuso
Read full article
Boomer income investors are entering August 2026 with a tricky setup. The 10-year Treasury yield sits at 4.67%, near its 12-month high of 4.71%, while CPI is running in the 81.8th percentile of its 12-month range and the 2026 Social Security COLA has already been baked in at 2.8%.
Read full article
Bank of America Corp DE cut its position in shares of Altria Group, Inc. (NYSE: MO) by 5.2% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,099,821 shares of the company's stock after selling 823,167 shares during the period.
Read full article
Altria Group is poised to announce its 56th consecutive annual dividend increase in August, with a predicted 3.7–4.7% boost to $4.40–$4.44. MO continues its transformation toward non-tobacco nicotine products, targeting mid-single-digit EPS and dividend growth through 2028 despite ongoing cigarette sales declines. Predicted forward yield for MO is 6.44–6.50%, underpinned by a 5-year compounded dividend growth rate of 4.1% and consistent EPS delivery.
Read full article
Levi & Korsinsky is investigating whether Altria Group misdescribed the FDA regulatory status of its on! PLUS nicotine pouch product and the likelihood of near-term FDA authorizations for additional applications.
Read full article
Altria Group NYSE: MO reported higher adjusted earnings for the second quarter and first half of 2026, supported by pricing in its smokable-products business, growth in its nicotine pouch portfolio and continued shareholder returns. The company raised the lower end of its full-year adjusted earnings guidance while citing ongoing pressure on nicotine consumers from inflation and elevated gas prices.
Read full article
MO highlights on! PLUS expansion, smoke-free growth plans and shareholder returns as it narrows 2026 earnings outlook.
Read full article
Sin stock sectors, including alcohol, tobacco, cannabis, firearms and gambling, attract investors with resilient cash flows, pricing power and defensive demand despite regulatory, litigation and ESG risks.
Read full article
The headline numbers for Altria (MO) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read full article
MO's second-quarter earnings miss estimates as cigarette shipments fall, though higher pricing lifted smokeable products revenues and supported profit growth.
Read full article